Recro Pharma Inc. (REPH)
NASDAQ: REPH
· Real-Time Price · USD
2.09
-0.01 (-0.48%)
At close: Mar 22, 2022, 5:00 AM
Recro Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.27M | -17.18M | -20.3M | -19.88M | -13.07M | -13.23M | -8.87M | -11.37M | -20.68M | -19.32M | -26.57M |
Depreciation & Amortization | 8.91M | 6.37M | 8.39M | 8.32M | 8.13M | 7.87M | 7.5M | 7.57M | 7.67M | 7.98M | 8.48M |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | 10.65M | 12.43M | 6.23M | -700K | 1.23M | -1.19M | 4.09M | 6.65M | 47.26M | 92.9M |
Other Non-Cash Items | -1.74M | 217K | 217K | 1.48M | 2.54M | 3.99M | 2.26M | 2.46M | 3.43M | 3.29M | 6.48M |
Deferred Income Tax | 89K | 1.09M | 1.09M | 1.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 5.54M | 7.2M | n/a | -3.08M | -963K | -2.88M | 5.68M | 10.47M | 6.17M | 7.25M |
Operating Cash Flow | -1M | -386K | 1.58M | -3.64M | -1.2M | 2.01M | 2.87M | 10.86M | 9.25M | 7.57M | 5.61M |
Capital Expenditures | -8.24M | -8.42M | -10.02M | -8.35M | -8.14M | -6.48M | -5.52M | -5.29M | -4.92M | -7.48M | -8.46M |
Cash Acquisitions | n/a | n/a | n/a | n/a | 4K | 4K | 4K | 4K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 24.01M | n/a | n/a | n/a | -24.01M | n/a | n/a |
Investing Cash Flow | -8.24M | -8.42M | -10.02M | -8.35M | -8.13M | -30.48M | -29.52M | -29.29M | -28.92M | -7.48M | -8.46M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | 101K | 101K | n/a | -297K | -390K | -516K | -751K | -555K | -462K | -336K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.34M | -381K | -547K | 1.77M | -2.58M | -1.77M | 30.37M | 19.89M | 21.67M | 22.84M | -5.47M |
Financial Cash Flow | 2.34M | -381K | -547K | 1.77M | -2.58M | -1.77M | 30.37M | 19.89M | 21.67M | 22.84M | -5.47M |
Net Cash Flow | -6.9M | -9.19M | -8.98M | -10.22M | -11.91M | -30.24M | 3.72M | 1.46M | 2M | 22.94M | -8.31M |
Free Cash Flow | -9.24M | -8.81M | -8.44M | -11.99M | -9.33M | -4.47M | -2.65M | 5.57M | 4.34M | 92K | -2.85M |